Severe Asthma (SA) is characterized by inadequate disease control despite maximal inhalation therapy. In November 2021, a 68-years old female patient presented at our facility referring a worsening in her asthma-related symptoms and a high exacerbations rate. She reported a liver transplantation in 2015 and was in treatment with tacrolimus. We started treatment with Mepolizumab 100 mg once every 28 days and monitored her lung function as well as her lymphocytes subsets. After one year follow-up, the patient had a substantial improvement in lung function, exacerbation rate, daily OCS intake dose and no variation in the blood concentration of tacrolimus.
Mepolizumab treatment in a patient with previous liver transplantation: One year follow-up / Candia, C.; Coppa, F.; Abagnale, L.; Perna, F.; Molino, A.. - In: RESPIRATORY MEDICINE CASE REPORTS. - ISSN 2213-0071. - 46:(2023). [10.1016/j.rmcr.2023.101933]
Mepolizumab treatment in a patient with previous liver transplantation: One year follow-up
Candia C.;Coppa F.;Abagnale L.;Perna F.;Molino A.
2023
Abstract
Severe Asthma (SA) is characterized by inadequate disease control despite maximal inhalation therapy. In November 2021, a 68-years old female patient presented at our facility referring a worsening in her asthma-related symptoms and a high exacerbations rate. She reported a liver transplantation in 2015 and was in treatment with tacrolimus. We started treatment with Mepolizumab 100 mg once every 28 days and monitored her lung function as well as her lymphocytes subsets. After one year follow-up, the patient had a substantial improvement in lung function, exacerbation rate, daily OCS intake dose and no variation in the blood concentration of tacrolimus.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
